Halsted WS. The results of Operations for the cure of Cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg. 1894;20:497–555.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thames HD. Early Fractionation methods and the origins of the NSD Concept. Acta Oncol. 1988;27:89–103.

Article  PubMed  Google Scholar 

Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer. 2004;4:737–47.

Article  CAS  PubMed  Google Scholar 

Kellerer AM, Rossi HH. The theory of dual radiation action. Curr Top Radiat Res. 1972;8:85–158.

CAS  Google Scholar 

Galecki J, Hicer-Grzenkowicz J, Grudzien-Kowalska M, Michalska T, Zalucki W. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer-a review. Acta Oncol. 2006;45:280–4.

Article  PubMed  Google Scholar 

Stoll BA, Andrews JT. Radiation-induced Peripheral Neuropathy. Br Med J. 1966;1:834–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johansson S, Svensson H, Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2002;52:1207–19.

Article  PubMed  Google Scholar 

Johansson S, Svensson H, Larsson LG, Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients–a long-term follow-up. Acta Oncol Stockh Swed. 2000;39:373–82.

Article  CAS  Google Scholar 

Moran MS, Truong PT. Hypofractionated radiation treatment for breast cancer: the time is now. Breast J. 2020;26:47–54.

Article  PubMed  Google Scholar 

Fisher B, Jeong J-H, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567–75.

Article  PubMed  Google Scholar 

Edward C, Halperin DE, Wazer CA, Perez, Luther W. Brady. Altered Fractionation Schedules. Perez Bradys Princ Pract Radiat Oncol. 6th ed. Philadelphia: Wolters Kluwer health - Lippincott Williams & Wilkins; 2013. pp. 278–96.

Google Scholar 

Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679–94.

Article  CAS  PubMed  Google Scholar 

Coutard H. Roentgen therapy of epitheliomas of the tonsillar region, hypopharynx and larynx from 1920 to 1926. Am J Roentgenol. 1932;28:313–32.

Google Scholar 

Steel GG, Deacon JM, Duchesne GM, Horwich A, Kelland LR, Peacock JH. The dose-rate effect in human tumour cells. Radiother Oncol J Eur Soc Ther Radiol Oncol. 1987;9:299–310.

Article  CAS  Google Scholar 

Matthews JH, Meeker BE, Chapman JD. Response of human tumor cell lines in vitro to fractionated irradiation. Int J Radiat Oncol Biol Phys. 1989;16:133–8.

Article  CAS  PubMed  Google Scholar 

Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2005;75:9–17.

Article  Google Scholar 

Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006;7:467–71.

Article  PubMed  Google Scholar 

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086–94.

Article  PubMed  Google Scholar 

Whelan TJ, Pignol J-P, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.

Article  CAS  PubMed  Google Scholar 

Qi XS, White J, Li XA. Is α/β for breast cancer really low? Radiother Oncol J Eur Soc Ther Radiol Oncol. 2011;100:282–8.

Article  Google Scholar 

Yarnold J. Early and locally advanced breast Cancer: diagnosis and Treatment National Institute for Health and Clinical Excellence Guideline 2009. Clin Oncol. 2009;21:159–60.

Article  CAS  Google Scholar 

Smith BD, Bentzen SM, Correa CR, Hahn CA, Hardenbergh PH, Ibbott GS, et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based Guideline. Int J Radiat Oncol. 2011;81:59–68.

Article  Google Scholar 

Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–55.

Article  CAS  PubMed  Google Scholar 

Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet Lond Engl. 1999;353:1641–8.

Article  CAS  Google Scholar 

Overgaard M, Nielsen HM, Tramm T, Højris I, Grantzau TL, Alsner J, et al. Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2022;170:4–13.

Article  Google Scholar 

Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116–26.

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network. Breast Cancer. (Version 4.2024). [cited 2024 Jul 29]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, et al. Postmastectomy Radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Pract Radiat Oncol. 2016;6:e219–34.

Article  PubMed  Google Scholar 

Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, et al. NRG Oncology/NSABP B-51/RTOG 1304: phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC). J Clin Oncol. 2019;37:TPS600–600.

Article  Google Scholar 

Wang S-L, Fang H, Song Y-W, Wang W-H, Hu C, Liu Y-P, et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019;20:352–60.

Article  PubMed  Google Scholar 

Poppe MM, Yehia ZA, Baker C, Goyal S, Toppmeyer D, Kirstein L, et al. 5-Year update of a Multi-institution, prospective phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial. Int J Radiat Oncol. 2020;107:694–700.

Article  Google Scholar 

Khan AJ, Poppe MM, Goyal S, Kokeny KE, Kearney T, Kirstein L, et al. Hypofractionated Postmastectomy Radiation Therapy is safe and effective: first results from a prospective phase II trial. J Clin Oncol. 2017;35:2037–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet Lond Engl. 2014;383:2127–35.

Article  Google Scholar 

Mutter RW, Giri S, Fruth BF, Remmes NB, Boughey JC, Harless CA, et al. Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial. Lancet Oncol. 2023;24:1083–93.

Article  PubMed  PubMed Central  Google Scholar 

Wong JS, Uno H, Tramontano AC, Fisher L, Pellegrini CV, Abel GA, et al. Hypofractionated vs conventionally fractionated Postmastectomy Radiation after Implant-Based Reconstruction: a Randomized Clinical Trial. JAMA Oncol. 2024;10:1370.

Article  PubMed  Google Scholar 

Poppe MM, Le-Rademacher J, Haffty BG, Hansen EK, Agarwal J, Wagner J, et al. A Randomized Trial of Hypofractionated Post